article thumbnail

As AI pervades biotech, what are investors looking for in 2023?

TechCrunch

billion of invested capital, continuing a downward trend for both metrics and representing the lowest for both since Q4 2019.” Six active biotech investors we surveyed recently told us that the macro environment has definitely had a big impact on deal flow, valuations and M&A in biotech.

Biotech 246
article thumbnail

6 investors discuss why AI is more than just a buzzword in biotech

TechCrunch

That’s why we weren’t very surprised when a slew of investors told us they rarely see a biotech startup that doesn’t incorporate AI in some form or other these days. But despite becoming quite the buzzword, AI’s apparent ubiquity in biotech isn’t actually driving deal flow or higher valuations.

Biotech 242
article thumbnail

Stämm Biotech raises $17M for its next-generation, 3D printed bioreactor

TechCrunch

Stämm Biotech , founded in 2014, is developing a desktop-sized bioreactor that looks pretty different from the tanks, tubes and knobs traditionally seen in industrial or even benchtop bioreactors. Image Credits: Stämm Biotech. Image Credits: Stämm Biotech. The movement itself acts as the stirring motion.

Biotech 226
article thumbnail

TechCrunch+ roundup: 7 VCs who are taking pitches, AI best practices, zero-based budgeting

TechCrunch

Zero-based budgeting: A proven framework for extending runway 5 strategies for biotech startups to outlast a market downturn Image Credits: Getty Images Spinning up a biotech company is a massive undertaking. “The best founders look for a framework to strategically cut burn while keeping their startup’s value drivers functioning.”

Budget 230
article thumbnail

H1’s LinkedIn for the healthcare industry raises $58 million

TechCrunch

. “When we started working with H1, we could already see early evidence of product-market fit, including both early ‘beachhead’ pharma deals and good logo velocity in smaller biotechs. “One of our diligence intros even turned into a multi-million dollar customer and investor.

article thumbnail

3 ways to break out of AI ‘pilot purgatory’

CIO

The biotech company Moderna , for example, is aiming to use ChatGPT Enterprise to “automate nearly every business process” in order to “outpace its plan to roll out 15 new products within the next five years.” The table below is a “genAI strategy sponsor” cheat sheet for bootstrapping vision, crafting metrics, and driving progress.

article thumbnail

14 climate tech investors share their H1 2022 strategies

TechCrunch

Which metrics do you use to gauge the health or viability of your climate tech investments? Is there a metric that helps you be more comfortable when cutting a check? That being said, I think a lot of this is also like a stage process. We think we can make the types of returns that we’re seeking in venture-style investments.